Bajaj Healthcare

May 8 (Reuters) - Bajaj Healthcare Ltd BAJH.NS:

• BAJAJ HEALTHCARE LTD MARCH-QUARTER LOSS 228.5 MILLION RUPEES

• BAJAJ HEALTHCARE LTD MARCH-QUARTER REVENUE FROM OPERATIONS 1.53 BILLION RUPEES

Source text: [ID:]

Further company coverage: BAJH.NS

(([email protected];))

Jan 16 (Reuters) - Bajaj Healthcare Ltd BAJH.NS:

• DEC-QUARTER PROFIT 156.7 MILLION RUPEES

• DEC-QUARTER REVENUE FROM OPERATIONS 1.61 BILLION RUPEES

• SAJANKUMAR BAJAJ RE-APPOINTED AS CHAIRMAN & MANAGING DIRECTOR

Further company coverage: BAJH.NS

(([email protected];))

Dec 31 (Reuters) - Bajaj Healthcare Ltd BAJH.NS:

• RECEIVES CDSCO APPROVAL FOR SUVOREXANT TABLETS TRIAL

Source text: ID:nBSE8Fb7pz

Further company coverage: BAJH.NS

(([email protected];;))

July 28 (Reuters) - Bajaj Healthcare Ltd BAJH.NS:

• JUNE-QUARTER PROFIT 118.3 MILLION RUPEES

• JUNE-QUARTER REVENUE FROM OPERATIONS 1.49 BILLION RUPEES

Source text: ID:nBSE6bpttP

Further company coverage: BAJH.NS

(([email protected];))

April 10 (Reuters) - Bajaj Healthcare Ltd BAJH.NS:

• APPROVED APPOINTMENT OF ROHAN PAREKH AS A CHIEF FINANCIAL OFFICER

Source text: [ID:]

Further company coverage: BAJH.NS

(([email protected];))

April 7 (Reuters) - Bajaj Healthcare Ltd BAJH.NS:

• ACQUISITION OF GENRX PHARMACEUTICALS FOR 108.5 MILLION RUPEES

Source text: [ID:]

Further company coverage: BAJH.NS

(([email protected];;))

April 2 (Reuters) - Bajaj Healthcare Ltd BAJH.NS:

• DAYASHANKAR PATEL RESIGNS AS CFO

Source text: ID:nBSE8Gc95N

Further company coverage: BAJH.NS

(([email protected];;))

** Shares of Bajaj Healthcare BAJH.NS rise as much as 10.3% to hit record high at 745 rupees

** The pharmaceutical co says its has secured SEC-CDSCO nod for Phase III clinical trials of anti-seizure medication Cenobamate tablets

** Phase III clinical trials are the final stage of drug development before regulatory approval - BAJH

** Stock on track for a third consecutive session of gain, if trend holds

** Stock is witnessing its most active trading session since January 29, with more than 1.3 mln shares changing hands, 3.3x of 30-day avg

** Stock last up 6%, taking YTD gains to 25%

(Reporting by Ashish Chandra in Bengaluru)

(([email protected] (+91 7982114624))

Jan 30 (Reuters) - Bajaj Healthcare Ltd BAJH.NS:

• GETS APPROVAL FROM DCGI TO MANUFACTURE API AND DRUG FORMULATION OF PIMAVANSERIN

Source text: [ID:]

Further company coverage: BAJH.NS

(([email protected];;))

** Shares of pharma co Bajaj Healthcare BAJH.NS rise as much as 4.7% to 451.80 rupees, hitting their highest since Oct 2023; last up 3.6%

** Co's active pharmaceutical ingredient (API) manufacturing site in Gujarat gets approval from Therapeutic Goods Administration, Australia

** Approval for direct supply of API to Australia and New Zealand

** More than 741,000 shares change hand, about five times the 30-day avg

** Stock up ~19% so far this year vs a ~21% rise in peer Aarey Drugs and Pharmaceuticals ADPH.NS

(Reporting by Dimpal Gulwani in Bengaluru)

(([email protected]))

Dec 6 (Reuters) - Bajaj Healthcare Ltd BAJH.NS:

• APPROVAL FROM THERAPEUTIC GOODS ADMINISTRATION (TGA), AUSTRALIA

• CO'S API MANUFACTURING SITE AT VADODARA GETS APPROVAL FROM TGA AUSTRALIA

• VADODARA SITE HAS ALREADY RECEIVED APPROVAL FROM USFDA AND EU

• TGA APPROVAL VALID FOR 24 MONTHS

Source text: ID:nBSE374MtW

Further company coverage: BAJH.NS

(([email protected];;))

** Shares of Bajaj Healthcare BAJH.NS rise as much as 6.9% to 404.40 rupees

** Pharmaceutical co says entered into a development and supply agreement for an active pharmaceutical ingredient(API) with a European entity

** Adds that API will be used by the EU partner to carry out clinical trials after its development

** Stock up 18% so far this quarter, on track for second straight quarterly gains

** Stock up 6.7% YTD

(Reporting by Ashish Chandra in Bengaluru)

(([email protected] (+91 7982114624))

July 5 (Reuters) - Bajaj Healthcare Ltd BAJH.NS:

• TO CONSIDER RAISING OF FUNDS

Further company coverage: BAJH.NS

(([email protected];))

May 6 (Reuters) - Bajaj Healthcare Ltd BAJH.NS:

• APPOINTS DAYASHANKAR PATEL AS CFO

Source text for Eikon: ID:nBSE5TVcLJ

Further company coverage: BAJH.NS

(([email protected];))

** Shares of Bajaj Healthcare BAJH.NS up 15% in heavy vols

** Pharma co enters into agreement with UK/EU-based customers to supply 15 Active Pharmaceutical Ingredients

** BAJH set for best day in six months, if trend holds

** Stock sees most active day in 2024, trading vols 18X the 30-day avg

** Session's gains help BAJH turn green for the month

** BAJH up ~11% in February, after falling ~11% in January

(Reporting by Nishit Navin in Bengaluru)

(([email protected];))

Feb 9 (Reuters) - Bajaj Healthcare Ltd BAJH.NS:

• BAJAJ HEALTHCARE DEC-QUARTER LOSS 22 MILLION RUPEES VERSUS PROFIT 110.5 MILLION RUPEES

• BAJAJ HEALTHCARE DEC-QUARTER REVENUE FROM OPERATIONS 1.09 BILLION RUPEES VERSUS 1.33 BILLION RUPEES

Source text for Eikon: ID:nBSE6VNNGZ

Further company coverage: BAJH.NS

(([email protected];))

Dec 1 (Reuters) - Bajaj Healthcare Ltd BAJH.NS:

• CFO RUPESH NIKAM RESIGNS

Further company coverage: BAJH.NS

(([email protected];))

** Shares of Bajaj Healthcare BAJH.NS rise as much as 7.4% to 406.5 rupees, biggest intraday gain since Sept. 22

** Co says it expects demand to improve in coming quarters

** Management confident of continued growth in EBITDA margin for 2HFY24 due to focus on more value added products, increase in exports and successful commissioning of Alkaloid Extraction Plant

** More than 394,391 shares traded by 02:10 p.m. IST, 1.4x the 30-day avg

** Stock currently up 4.6% trimming YTD losses to 10%

(Reporting by Ashna Teresa Britto in Bengaluru)

(([email protected] ; ( +91 8078332441))

Oct 18 (Reuters) - Bajaj Healthcare Ltd BAJH.NS:

• SUCCESSFUL COMMISSIONING OF ALKALOID EXTRACTION PLANT IN VADODARA

Source text for Eikon: ID:nNSETrj6c

Further company coverage: BAJH.NS

(([email protected];))

** Shares of Bajaj Healthcare BAJH.NS rise as much as 8.2% to 446 rupees, highest since Jan. 4

** Stock set to rise for a second straight session if gains hold

** Co on Wednesday said it received U.S. FDA's establishment inspection report for its manufacturing site in Vadodara

** EIR had zero 483 observations, co added

** More than 970,000 shares change hands by 10:21 a.m. IST, 3.1x 30-day avg

** Volume above 800,000 for fourth session this month

** Stock up 2.6% as of 10:21 a.m. IST, trimming YTD losses to 4.9%

(Reporting by Anuran Sadhu in Bengaluru)

(([email protected] ;))

** Shares of Bajaj Healthcare BAJH.NS rise as much as 7% to 323.6 rupees, highest since June 16

** Co on Wednesday approved sale of two plots in Maharashtra and one in Gujarat

** Facilities closed due to delay in getting various regulatory approvals and co being unable to amend processes for the products already manufactured in said units

** Co on track for second consecutive session of gains, if trends stand

** More than 85,909 shares change hands by 09:30 a.m. IST vs 1.2x 30-day avg of 73,546 shares

** Stock down 31.9% YTD up to last close

(Reporting by Ashna Teresa Britto in Bengaluru)

(([email protected] ; ( +91 8078332441))

June 28 (Reuters) - Bajaj Healthcare Ltd BAJH.NS:

• APPROVED SALE OF 2 PLOTS IN MAHARASHTRA AND ONE IN GUJARAT

Source text for Eikon: ID:nNSEM155T

Further company coverage: BAJH.NS

(([email protected];))

May 30 (Reuters) - Bajaj Healthcare Ltd BAJH.NS:

• INDIA'S BAJAJ HEALTHCARE LTD MARCH-QUARTER PROFIT 35.9 MILLION RUPEES VERSUS PROFIT 174.7 MILLION RUPEES

• BAJAJ HEALTHCARE LTD MARCH-QUARTER REVENUE FROM OPERATIONS 1.58 BILLION RUPEES VERSUS 1.76 BILLION RUPEES

• BAJAJ HEALTHCARE LTD - DIVIDEND 1 RUPEE PER SHARE

Source text for Eikon: ID:nBSE6BYSPC

Further company coverage: BAJH.NS

(([email protected];))

April 18 (Reuters) - Bajaj Healthcare Ltd BAJH.NS:

• APPROVED RE-APPOINTMENT OF SAJANKUMAR BAJAJ AS CHAIRMAN AND MANAGING DIRECTOR

• RE-APPOINTS ANIL JAIN AS MANAGING DIRECTOR

Source text for Eikon: ID:nBSE5XlRX7

Further company coverage: BAJH.NS

(([email protected];))